Company intelligence / Profile preview
Xinjiang Uygur Pharmaceutical Co., Ltd.
Urumqi, Xinjiang Uygur Autonomous Region, Chinaxj-wy.cn ↗
- Ownership
- Private
- Employees
- ~600
- Development stage
- Commercial
01
Overview
The company has multiple products in various clinical stages, including Wenwei Ayaranji Tablets (Phase 3), Xing Qi Tan Ni Ka Er Capsule (Phase 2), Qubai Bairesi Tincture (Phase 2), and Flos gossypii flavonoids tablet (Phase 2)[2].
- Therapeutic areas
- GastroenterologyDermatologyRheumatologyNeurology
- Modalities
- Herbal medicineTraditional Uygur medicine
- Industry
- Biotech
02
Drug pipeline
17 assets16 more assets in the full pipeline.
03
Partnerships
Uygur Medicine Hospital of the Xinjiang Uygur Autonomous Region (co-founder)
Beyond the preview
Go deeper on Xinjiang Uygur Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinjiang Uygur Pharmaceutical Co., Ltd..